gatifloxacin has been researched along with Cancer of Prostate in 1 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takeyama, K | 1 |
| Mitsuzawa, H | 1 |
| Nishitani, C | 1 |
| Shimizu, T | 1 |
| Sano, H | 1 |
| Kunishima, Y | 1 |
| Takahashi, S | 1 |
| Hotta, H | 1 |
| Matsukawa, M | 1 |
| Shibata, K | 1 |
| Tsukamoto, T | 1 |
| Kuroki, Y | 1 |
1 other study available for gatifloxacin and Cancer of Prostate
| Article | Year |
|---|---|
The 6-fluoro-8-methoxy quinolone gatifloxacin down-regulates interleukin-8 production in prostate cell line PC-3.
Topics: Anti-Infective Agents; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Down-Regul | 2007 |